Miller and colleagues conducted a more recent analysis of the same database and discovered that 10.1% of adolescents in the United States had MetS (12)
Following her March 27, 2024 diagnosis of gastroparesis, Plaintiff was told by her treating physicians that Ozempic was the probable cause of her injuries and she was recommended to discontinue the medication, the lawsuit states
Its not a sign that youve failed or that your body is broken
[2, 3] It may be an option to consider if you are entering a phase of weight maintenance and would prefer to avoid injections long-term
So your prescriber can help match you with the option that best fits your needs: Ozempic: Approved for Type 2 diabetes and to lower the risk of serious cardiovascular and kidney-related problems in certain people Wegovy: Approved for weight loss and to lower the risk of serious cardiovascular problems if you have heart disease and a larger body size Mounjaro:Approved for Type 2 diabetes Zepbound: Approved for weight loss and moderate-to-severe obstructive sleep apnea (OSA) Be prepared to share details about your current compounded GLP-1 prescription
Inflammatory bowel disease includes ulcerative colitis and possibly, Crohns disease
